448 related articles for article (PubMed ID: 19821349)
1. Vitamin D compounds for people with chronic kidney disease requiring dialysis.
Palmer SC; McGregor DO; Craig JC; Elder G; Macaskill P; Strippoli GF
Cochrane Database Syst Rev; 2009 Oct; (4):CD005633. PubMed ID: 19821349
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D compounds for people with chronic kidney disease not requiring dialysis.
Palmer SC; McGregor DO; Craig JC; Elder G; Macaskill P; Strippoli GF
Cochrane Database Syst Rev; 2009 Oct; (4):CD008175. PubMed ID: 19821446
[TBL] [Abstract][Full Text] [Related]
3. Interventions for metabolic bone disease in children with chronic kidney disease.
Hahn D; Hodson EM; Craig JC
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008327. PubMed ID: 26561037
[TBL] [Abstract][Full Text] [Related]
4. Interventions for bone disease in children with chronic kidney disease.
Geary DF; Hodson EM; Craig JC
Cochrane Database Syst Rev; 2010 Jan; (1):CD008327. PubMed ID: 20091666
[TBL] [Abstract][Full Text] [Related]
5. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
Ballinger AE; Palmer SC; Nistor I; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2014; 2014(12):CD006254. PubMed ID: 25490118
[TBL] [Abstract][Full Text] [Related]
6. Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.
Navaneethan SD; Palmer SC; Vecchio M; Craig JC; Elder GJ; Strippoli GF
Cochrane Database Syst Rev; 2011 Feb; (2):CD006023. PubMed ID: 21328279
[TBL] [Abstract][Full Text] [Related]
7. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
Strippoli GF; Tong A; Palmer SC; Elder G; Craig JC
Cochrane Database Syst Rev; 2006 Oct; (4):CD006254. PubMed ID: 17054287
[TBL] [Abstract][Full Text] [Related]
8. Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.
Palmer SC; Teixeira-Pinto A; Saglimbene V; Craig JC; Macaskill P; Tonelli M; de Berardis G; Ruospo M; Strippoli GF
Am J Kidney Dis; 2015 Dec; 66(6):962-71. PubMed ID: 26003472
[TBL] [Abstract][Full Text] [Related]
9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
10. Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
Liu Z; Su G; Guo X; Wu Y; Liu X; Zou C; Zhang L; Yang Q; Xu Y; Ma W
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010350. PubMed ID: 26376110
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis: vitamin D compounds in chronic kidney disease.
Palmer SC; McGregor DO; Macaskill P; Craig JC; Elder GJ; Strippoli GF
Ann Intern Med; 2007 Dec; 147(12):840-53. PubMed ID: 18087055
[TBL] [Abstract][Full Text] [Related]
12. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Navaneethan SD; Palmer SC; Craig JC; Elder GJ; Strippoli GF
Am J Kidney Dis; 2009 Oct; 54(4):619-37. PubMed ID: 19692157
[TBL] [Abstract][Full Text] [Related]
15. Interventions for preventing bone disease in kidney transplant recipients.
Palmer SC; McGregor DO; Strippoli GF
Cochrane Database Syst Rev; 2007 Jul; (3):CD005015. PubMed ID: 17636784
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials.
Kandula P; Dobre M; Schold JD; Schreiber MJ; Mehrotra R; Navaneethan SD
Clin J Am Soc Nephrol; 2011 Jan; 6(1):50-62. PubMed ID: 20876671
[TBL] [Abstract][Full Text] [Related]
17. Interventions for treating sexual dysfunction in patients with chronic kidney disease.
Vecchio M; Navaneethan SD; Johnson DW; Lucisano G; Graziano G; Saglimbene V; Ruospo M; Querques M; Jannini EA; Strippoli GF
Cochrane Database Syst Rev; 2010 Dec; (12):CD007747. PubMed ID: 21154382
[TBL] [Abstract][Full Text] [Related]
18. Mortality risk among hemodialysis patients receiving different vitamin D analogs.
Tentori F; Hunt WC; Stidley CA; Rohrscheib MR; Bedrick EJ; Meyer KB; Johnson HK; Zager PG;
Kidney Int; 2006 Nov; 70(10):1858-65. PubMed ID: 17021609
[TBL] [Abstract][Full Text] [Related]
19. Cinacalcet plus vitamin D versus vitamin D alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: a meta-analysis of randomized controlled trials.
Xu J; Yang Y; Ma L; Fu P; Peng H
Int Urol Nephrol; 2019 Nov; 51(11):2027-2036. PubMed ID: 31531805
[TBL] [Abstract][Full Text] [Related]
20. Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.
Strippoli GF; Navaneethan SD; Craig JC
Cochrane Database Syst Rev; 2006 Oct; (4):CD003967. PubMed ID: 17054191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
